[1]
Zègre-Hemsey JK, Asafu-Adjei J, Fernandez A, Brice J. Characteristics of Prehospital Electrocardiogram Use in North Carolina Using a Novel Linkage of Emergency Medical Services and Emergency Department Data. Prehospital emergency care. 2019 Nov-Dec:23(6):772-779. doi: 10.1080/10903127.2019.1597230. Epub 2019 Apr 17
[PubMed PMID: 30885071]
[2]
Alomari M, Bratton H, Musmar A, Al Momani LA, Young M. Ticagrelor-induced Diarrhea in a Patient with Acute Coronary Syndrome Requiring Percutaneous Coronary Artery Intervention. Cureus. 2019 Jan 12:11(1):e3874. doi: 10.7759/cureus.3874. Epub 2019 Jan 12
[PubMed PMID: 30899625]
[3]
Kerneis M, Nafee T, Yee MK, Kazmi HA, Datta S, Zeitouni M, Afzal MK, Jafarizade M, Walia SS, Qamar I, Pitliya A, Kalayci A, Al Khalfan F, Gibson CM. Most Promising Therapies in Interventional Cardiology. Current cardiology reports. 2019 Mar 13:21(4):26. doi: 10.1007/s11886-019-1108-x. Epub 2019 Mar 13
[PubMed PMID: 30868280]
[5]
Voudris KV,Kavinsky CJ, Advances in Management of Stable Coronary Artery Disease: the Role of Revascularization? Current treatment options in cardiovascular medicine. 2019 Mar 11;
[PubMed PMID: 30854580]
Level 3 (low-level) evidence
[6]
Pop C, Matei C, Petris A. Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances. American journal of therapeutics. 2019 Mar/Apr:26(2):e184-e197. doi: 10.1097/MJT.0000000000000913. Epub
[PubMed PMID: 30839367]
Level 3 (low-level) evidence
[7]
Luciano LSC,Silva RLD,Londero Filho OM,Waldrich L,Panata L,Trombetta AP,Preve JC,Fattah T,Giuliano LC,Thiago LEKS, Analysis of the Appropriate Use Criteria for Coronary Angiography in Two Cardiology Services of Southern Brazil. Arquivos brasileiros de cardiologia. 2019 May
[PubMed PMID: 30892387]
[8]
Campanile A, Castellani C, Santucci A, Annunziata R, Tutarini C, Reccia MR, Del Pinto M, Verdecchia P, Cavallini C. Predictors of in-hospital and long-term mortality in unselected patients admitted to a modern coronary care unit. Journal of cardiovascular medicine (Hagerstown, Md.). 2019 May:20(5):327-334. doi: 10.2459/JCM.0000000000000785. Epub
[PubMed PMID: 30865139]
[9]
Chen WWC, Law KK, Li SK, Chan WCK, Cheong A, Fong PC, Hung YT, Lai SWK, Leung GTC, Wong EML, Wong RWK, Yan CT, Yan VWT, Au Yeong TCK. Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations. Internal medicine journal. 2019 Mar:49 Suppl 1():5-8. doi: 10.1111/imj.14153. Epub
[PubMed PMID: 30815979]
[10]
Duarte GS, Nunes-Ferreira A, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J, Caldeira D. Morphine in acute coronary syndrome: systematic review and meta-analysis. BMJ open. 2019 Mar 15:9(3):e025232. doi: 10.1136/bmjopen-2018-025232. Epub 2019 Mar 15
[PubMed PMID: 30878985]
Level 1 (high-level) evidence
[11]
Gilutz H,Shindel S,Shoham-Vardi I, Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality. Critical pathways in cardiology. 2019 Mar;
[PubMed PMID: 30747764]
[12]
Klein MD, Williams AK, Lee CR, Stouffer GA. Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention. Arteriosclerosis, thrombosis, and vascular biology. 2019 Apr:39(4):647-652. doi: 10.1161/ATVBAHA.118.311963. Epub
[PubMed PMID: 30760018]
[13]
Abdur Rehman K, Wazni OM, Barakat AF, Saliba WI, Shah S, Tarakji KG, Rickard J, Bassiouny M, Baranowski B, Tchou PJ, Bhargava M, Dresing TJ, Callahan TD, Cantillon DJ, Chung M, Kanj M, Irefin S, Lindsay B, Hussein AA. Life-Threatening Complications of Atrial Fibrillation Ablation: 16-Year Experience in a Large Prospective Tertiary Care Cohort. JACC. Clinical electrophysiology. 2019 Mar:5(3):284-291. doi: 10.1016/j.jacep.2018.11.013. Epub 2019 Jan 30
[PubMed PMID: 30898229]
[14]
Xia K, Wang LF, Yang XC, Jiang HY, Zhang LJ, Yao DK, Hu DY, Ding RJ. Comparing the effects of depression, anxiety, and comorbidity on quality-of-life, adverse outcomes, and medical expenditure in Chinese patients with acute coronary syndrome. Chinese medical journal. 2019 May 5:132(9):1045-1052. doi: 10.1097/CM9.0000000000000215. Epub
[PubMed PMID: 30896567]
Level 2 (mid-level) evidence
[15]
Ahn KT,Seong SW,Choi UL,Jin SA,Kim JH,Lee JH,Choi SW,Jeong MH,Chae SC,Kim YJ,Kim CJ,Kim HS,Cho MC,Gwon HC,Jeong JO,Seong IW, Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. Medicine. 2019 Mar;
[PubMed PMID: 30882670]
Level 2 (mid-level) evidence